Home > PS Ratio > SHILPA MEDICARE

SHILPA MEDICARE
PS (Price/Sales) Ratio

The Current P/S Ratio of SHILPA MEDICARE is 4.18.

Share Price ₹540.5Apr 16,2024
Market Cap ₹4,691.1 Cr
Sales-TTM₹1,123.2 CrTTM-Consolidated Results
Price/Sales4.18xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SHILPA MEDICARE
Please provide your vote to see the results
SHILPA MEDICARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SHILPA MEDICARE

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SHILPA MEDICARE is calculated as :

Current Market Cap [ ₹4,691.1 Cr] as on Apr 16,2024

(/) Sales [ ₹1,123.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 4.18x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SHILPA MEDICARE , the investors are currently willing to pay '4.18 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SHILPA MEDICARE !

The chart below summarizes the trend in P/S Ratio of SHILPA MEDICARE over the last five years.

Historical PS (Price/Sales) ratio chart of SHILPA MEDICARE


PS Ratio Performance Analysis for SHILPA MEDICARE

- SHILPA MEDICARE 's latest p/e ratio is 4.18x.

- SHILPA MEDICARE 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 2.78x.

- SHILPA MEDICARE 's operated at median p/e ratio of 3.01x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SHILPA MEDICARE 's p/e ratio peaked in Mar2019 at 3.78x.

- SHILPA MEDICARE 's p/e ratio hit its five-year low in Mar2023 of 1.9x.


How does SHILPA MEDICARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SHILPA MEDICARE 1,123.24.184,691.1
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.77368,766.0
CIPLA LTD25,350.24.38111,102.0
DR REDDYS LABORATORIES LTD27,212.53.71100,958.0
ZYDUS LIFESCIENCES LTD19,024.25.0095,104.2
DIVIS LABORATORIES LTD7,492.813.3499,939.6
MANKIND PHARMA LTD9,946.39.1991,420.3
TORRENT PHARMACEUTICALS LTD10,474.08.2085,851.8
LUPIN LTD19,480.13.7673,329.7
AUROBINDO PHARMA LTD27,894.72.3365,027.5
ABBOTT INDIA LTD5,753.49.6455,442.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHILPA MEDICARE 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.33x
Max industry PS 13.34x
Median industry PS 5.00x
Average industry PS 6.50x



You may also like the below Video Courses